Anti-CD147 CAR T cell therapy (Xijing Hospital)

N/A

Report date: 2024/11/20 20:00:31

Base Information

Drug NameAnti-CD147 CAR T cell therapy (Xijing Hospital)

Drug Alias Name抗CD147嵌合抗原受体T细胞疗法-西京医院anti-CD147 chimeric antigen receptor T cell therapy

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Gene therapy

Mechanisms of ActionAnti-CD147

TargetsBasigin

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaPending

Originator CompaniesThe First Affiliated Hospital of Air Force Medical University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe First Affiliated Hospital of Air Force Medical University

Active IndicationsN/A

Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A